Marco Gobbi

2PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 04, 2022
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.

Amer M Zeidan, Pierre Fenaux, Marco Gobbi

|Dec 30, 2020
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden.

Paola Minetto, Anna Candoni, Fabio Guolo

Pageof 1

Frequent Collaborators

1 joint publications

Paola Minetto

1 joint publications

Anna Candoni

1 joint publications

Fabio Guolo

1 joint publications

Luca Lanino